Valuation: Becton, Dickinson and Company

Market Cap 5.4TCr 4.82TCr 4.43TCr 4.02TCr 7.56TCr 5,11300Cr 7.74TCr 53TCr 21TCr 2,69900Cr 20TCr 20TCr 8,55400Cr P/E 2026 *
40.4x
P/E 2027 * 23.3x
Enterprise Value 6.99TCr 6.24TCr 5.73TCr 5.21TCr 9.78TCr 6,61800Cr 10TCr 68TCr 28TCr 3,49300Cr 26TCr 26TCr 11,07100Cr EV / Sales 2026 *
3.62x
EV / Sales 2027 * 3.44x
Free-Float
73.18%
Yield 2026 *
2.11%
Yield 2027 * 2.15%
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-5.43% - - 5.4TCr
-0.69%+6.11%-11.66%+14.15% 19TCr
-0.41%+5.25%+9.62%+36.27% 12TCr
+1.22%+3.03%-13.29%+12.43% 12TCr
-0.38%+3.26%-42.00%+6.28% 9.48TCr
+0.79%+4.65%-0.13%+74.46% 6.5TCr
-0.22%+1.61%+11.77%-23.46% 5.4TCr
+0.06%+19.74%-7.04%+56.54% 5.29TCr
-1.45%-7.57%-2.88%+55.56% 5.23TCr
+0.23%+3.85%-1.42%-10.23% 3.52TCr
Average +0.06%+4.25%-6.34%+24.67% 8.7TCr
Weighted average by Cap. +0.22%+4.39%-8.36%+23.31%

Financials

2026 *2027 *
Net sales 1.93TCr 1.72TCr 1.58TCr 1.44TCr 2.7TCr 1,82700Cr 2.77TCr 19TCr 7.6TCr 96TCr 7.24TCr 7.09TCr 3,05700Cr 1.97TCr 1.76TCr 1.62TCr 1.47TCr 2.76TCr 1,86900Cr 2.83TCr 19TCr 7.77TCr 99TCr 7.41TCr 7.25TCr 3,12600Cr
Net income 140.63Cr 125.64Cr 115.41Cr 104.81Cr 196.83Cr 13TCr 201.78Cr 1.38TCr 554.17Cr 7.03TCr 527.86Cr 516.56Cr 22TCr 219.2Cr 195.83Cr 179.88Cr 163.37Cr 306.8Cr 21TCr 314.51Cr 2.15TCr 863.78Cr 11TCr 822.77Cr 805.17Cr 35TCr
Net Debt 1.59TCr 1.42TCr 1.3TCr 1.18TCr 2.22TCr 1,50500Cr 2.28TCr 16TCr 6.26TCr 79TCr 5.96TCr 5.83TCr 2,51700Cr 1.4TCr 1.25TCr 1.14TCr 1.04TCr 1.95TCr 1,32200Cr 2TCr 14TCr 5.5TCr 70TCr 5.24TCr 5.12TCr 2,21100Cr
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
198.17USD
Average target price
195.57USD
Spread / Average Target
-1.31%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company